# R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

> **NCT06926894** · PHASE1 · RECRUITING · sponsor: **Columbia University** · enrollment: 18 (estimated)

## Conditions studied

- Epstein-Barr Virus
- Cytomegalovirus Infections
- Adenovirus
- BK Virus Infection
- Immune Deficiency

## Interventions

- **DRUG:** Rapidly generated virus specific T (R-MVST) cells

## Key facts

- **NCT ID:** NCT06926894
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-20
- **Primary completion:** 2029-04
- **Final completion:** 2030-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06926894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06926894, "R-MVST Cells for Treatment of Viral Infections in Children and Young Adults". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06926894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*